一、基本信息

姓名：曾位森                             

职称：教授

联系邮箱：zengws@smu.edu.cn

 

二、学习经历

1985.9-1988.7  赣南医学院，临床医学专业

1991.9-1994.7  湖南医科大学，医学遗传学专业，硕士

 

三、拟招收博士后开展的研究方向

1. 基因工程益生菌生物治疗与药物开发；

2. 糖脂代谢异常疾病发病机制。

 

四、主要学术任职

1. 中国基因工程学会，会员；

2. 中国细胞生物学会，会员。

 

五、主要获奖情况

广东省科技进步二等奖，2003

 

六、代表性论文

1. Long RT, Zeng WS *, Chen LY, J Guo, Lin YZ, Huang QS, Luo SQ *. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice. International Journal of Obesity 2010, 34(4):712-719.

2. Yao J, Wang LS, Wang JY, Lai MG, Li YX, Zhu HM, Shi RY, Mo J, Xun AY, Jia CH, Feng JL, Wang LS *,Zeng WS *, and L Liu*. Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum. Mol. Pharmaceutics, 2011; 8:488-497.

3. Shao CW, Tian GJ, Huang YJ, Liang WY, Zheng H, Wei JN, Wei C, Yang CL, Wang H,Zeng WS*. Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation 6 and maturation in mice by oral administration. International Immunopharmacology, 2013; 15:646-653.

4. Yu Zhijian, Huang Zhen, Sao Chongwen, Huang Yuanjian, Zhang Fan, Ma Guihong, Chen Zhong, Zeng Zhongming, Qiwen Deng*, Zeng Weiseng*. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. Arch Virol. 2013, 158(5): 1071-1077.

5. Zhijian Yu, Zhen Huang, Chongwen Sao, Yuanjian Huang, Fan Zhang, Jin Yang, Jie Lian,Zhongming Zeng, Wenshen Luo,Weisen Zeng*,Qiwen Deng*.Bifidobacterium as an oral delivery carrier of interleukin-12 for the treatment of Coxsackie virus B3-induced myocarditis in the Balb/c mice. International Immunopharmacology 2012, 12:125–130.